Clinical Trial Update: Tocilizumab for Painful Chronic Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 trial of tocilizumab for painful chronic pancreatitis is currently recruiting. The study is sponsored by Soren Schou Olesen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Actemra (tocilizumab) (tocilizumab)

Snippet

Sponsor: Soren Schou Olesen | Conditions: Pancreatitis, Chronic | Phase 2 | Status: RECRUITING